HOB Biotech Group Corp.,Ltd (SHA:688656)
143.80
+1.50 (1.05%)
Jan 30, 2026, 3:00 PM CST
SHA:688656 Revenue
HOB Biotech Group Corp.,Ltd had revenue of 102.52M CNY in the quarter ending September 30, 2025, a decrease of -1.64%. This brings the company's revenue in the last twelve months to 387.48M, down -3.44% year-over-year. In the year 2024, HOB Biotech Group Corp.,Ltd had annual revenue of 402.34M with 2.01% growth.
Revenue (ttm)
387.48M
Revenue Growth
-3.44%
P/S Ratio
23.02
Revenue / Employee
732.48K
Employees
524
Market Cap
8.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 402.34M | 7.93M | 2.01% |
| Dec 31, 2023 | 394.41M | 74.01M | 23.10% |
| Dec 31, 2022 | 320.39M | 2.68M | 0.84% |
| Dec 31, 2021 | 317.71M | 95.85M | 43.20% |
| Dec 31, 2020 | 221.86M | -37.27M | -14.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| Sinocare | 4.71B |
| Cofoe Medical Technology | 3.13B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Qingdao Haier Biomedical Co.,Ltd | 2.26B |
| Shenzhen YHLO Biotech | 1.90B |
| Edan Instruments | 1.90B |
| INKON Life Technology | 1.69B |